These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16216889)

  • 1. Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL.
    Hegde NR; Dunn C; Lewinsohn DM; Jarvis MA; Nelson JA; Johnson DC
    J Exp Med; 2005 Oct; 202(8):1109-19. PubMed ID: 16216889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells.
    Tomazin R; Boname J; Hegde NR; Lewinsohn DM; Altschuler Y; Jones TR; Cresswell P; Nelson JA; Riddell SR; Johnson DC
    Nat Med; 1999 Sep; 5(9):1039-43. PubMed ID: 10470081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B.
    Hopkins JI; Fiander AN; Evans AS; Delchambre M; Gheysen D; Borysiewicz LK
    J Med Virol; 1996 Jun; 49(2):124-31. PubMed ID: 8991935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
    Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
    J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
    Johnson DC; Hegde NR
    Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H.
    Elkington R; Shoukry NH; Walker S; Crough T; Fazou C; Kaur A; Walker CM; Khanna R
    Eur J Immunol; 2004 Nov; 34(11):3216-26. PubMed ID: 15368271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules.
    Sinzger C; Eberhardt K; Cavignac Y; Weinstock C; Kessler T; Jahn G; Davignon JL
    J Gen Virol; 2006 Jul; 87(Pt 7):1853-1862. PubMed ID: 16760387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class II MHC molecules are spontaneously internalized in acidic endosomes by activated B cells.
    Weber DA; Buck LB; Delohery TM; Agostino N; Pernis B
    J Mol Cell Immunol; 1990; 4(5):255-66; discussion 266-8. PubMed ID: 2169757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences.
    Niazi KR; Ochoa MT; Sieling PA; Rooke NE; Peter AK; Mollahan P; Dickey M; Rabizadeh S; Rea TH; Modlin RL
    Immunology; 2007 Dec; 122(4):522-31. PubMed ID: 17635609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells.
    Hengel H; Esslinger C; Pool J; Goulmy E; Koszinowski UH
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():2987-97. PubMed ID: 8847504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
    Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
    J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC.
    Rowell JF; Stanhope PE; Siliciano RF
    J Immunol; 1995 Jul; 155(1):473-88. PubMed ID: 7602119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of the immune response to human cytomegalovirus glycoprotein B (gB). II. Low gB-specific T and B cell responses are associated with expression of certain HLA-DR alleles.
    Curtsinger JM; Liu YN; Radeke R; Bryon MK; Fuad S; Bach FH; Gehrz RC
    J Gen Virol; 1994 Feb; 75 ( Pt 2)():301-7. PubMed ID: 8113751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misdirection of endosomal trafficking mediated by herpes simplex virus-encoded glycoprotein B.
    Niazy N; Temme S; Bocuk D; Giesen C; König A; Temme N; Ziegfeld A; Gregers TF; Bakke O; Lang T; Eis-Hübinger AM; Koch N
    FASEB J; 2017 Apr; 31(4):1650-1667. PubMed ID: 28119397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes.
    Schmid D; Pypaert M; Münz C
    Immunity; 2007 Jan; 26(1):79-92. PubMed ID: 17182262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.